Ahamed Anish, Unnikrishnan Ambika Gopalakrishnan, Pendsey Sanket Sharad, Nampoothiri Sheela, Bhavani Nisha, Praveen Valliyaparambil Pavithran, Kumar Harish, Jayakumar Rohinivilasam Vasukutty, Nair Vasantha, Ellard Sian, Edghill Emma L
Department of Endocrinology, Amrita Institute of Medical Sciences, Cochin, India.
JOP. 2008 Nov 3;9(6):715-8.
Neonatal diabetes is a rare disorder with an incidence of 1 in 215,000-500,000 live births with 50% of them having permanent neonatal diabetes mellitus.
We present a case of permanent neonatal diabetes mellitus due to a C96Y (c.287G>A; p.Cys96Tyr) heterozygous mutation in the insulin (INS) gene. Both the patient and his father (who had childhood-onset insulin-requiring diabetes) were found to be carriers of a heterozygous missense mutation C96Y in exon 3 of the INS gene. It has been hypothesized that these mutations disrupt the folding of the proinsulin molecule and result in a misfolded protein or retention of the protein in the endoplasmic reticulum, resulting in endoplasmic reticulum stress and beta cell apoptosis. Subjects with this form of diabetes will need lifelong insulin therapy.
Insulin gene mutations appear to be an important cause of neonatal diabetes worldwide. This is the first report of a case from the Indian subcontinent. It is important to carry out genetic tests for mutations linked to pancreatic beta cell dysfunction in all patients with persistent neonatal diabetes mellitus in order to decide on therapy.
新生儿糖尿病是一种罕见疾病,在215,000至500,000例活产婴儿中的发病率为1/215,000 - 500,000,其中50%患有永久性新生儿糖尿病。
我们报告一例因胰岛素(INS)基因C96Y(c.287G>A;p.Cys96Tyr)杂合突变导致的永久性新生儿糖尿病病例。该患者及其父亲(患有儿童期起病的胰岛素依赖型糖尿病)均被发现是INS基因第3外显子杂合错义突变C96Y的携带者。据推测,这些突变会破坏胰岛素原分子的折叠,导致蛋白质错误折叠或在内质网中滞留,从而引发内质网应激和β细胞凋亡。患有这种形式糖尿病的患者需要终身胰岛素治疗。
胰岛素基因突变似乎是全球新生儿糖尿病的一个重要病因。这是来自印度次大陆的首例病例报告。对所有持续性新生儿糖尿病患者进行与胰腺β细胞功能障碍相关突变的基因检测以确定治疗方案非常重要。